title: Rilonacept (arcalyst), an interleukin-1 trap for the treatment of cryopyrin-associated periodic syndromes.
authors: Dr. Kapur is a Fellow, and Dr. Bonk is Manager of the Drug Information Group, both at the University HealthSystem Consortium in Oakbrook, Illinois. Drug Forecast is a regular column coordinated by Alan Caspi, PhD, PharmD, MBA, President of Caspi & Associates in New York, New York.
authors: Saloni
authors: S
authors: Kapur
authors: Mary Ellen
authors: ME
authors: Bonk